Survival Outcomes
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17450 | Albumin-stabilized nanoparticle (130 nm) | 2 | Recruiting | 1 |
| DB11885 | Anlotinib | 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB15414 | CM-4307 | 2 | Recruiting | 1 |
| DB14776 | Camrelizumab | 2 | Recruiting | 1 |
| DB11793 | Niraparib | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 2 |
| DB12257 | Platinum | 2 | Recruiting | 1 |
| DB14922 | Tislelizumab | 2 | Recruiting | 1 |